ifestyle Intervention in Chronic ischemic heart disease and Diabetes

Not Applicable

• Conditions: I25; E11; Chronic ischaemic heart disease; Type 2 diabetes mellitus

• Registration Number: DRKS00015140
• Lead Sponsor: Techniker Krankenkasse

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 502

Inclusion Criteria

Insured at participating health insurance,
Chronic ischemic heart disease (ICD-10: I25),
Diabetes mellitus type II (ICD-10: E11),
Permission to do sports by the study investigator,
Written informed consent

Exclusion Criteria

Mental and behavioral disorders (ICD-10: F0-F99),
Heart failure NYHA IV (ICD-10: I50.14),
Malignant neoplasm (ICD-10: C25, C34, C56, C72, C73, C78, C79, C97),
Parkinson’s disease (ICD-10: G20),
Alzheimer’s disease (ICD-10: G30),
infantile cerebral palsy (ICD-10: G80),
chronic kidney disease (ICD-10: N18),
Trisomy 21 (ICD-10: Q90),
Blindness / visual impairment (ICD-10: H54.0, H54.2, H54.3),
Hearing loss (ICD-10: H90.0, H90.3, H90.5, H90.6, H90.8),
Care level 1-5,
Assured in a foreign country,
Inability to exercise or conditions that may interfere with exercise intervention,
No optimal medical treatment within the last 4 weeks,
Not clinically stable within the last 4 weeks,
Participation in another clinical trial

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in HbA1c (%) within 6 months